در حال جستجو در محتوی

ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده: 4 مورد
نسخه الکترونیک
medimedia.ir
Acute lymphoblastic leukemia/lymphoblastic lymphoma: Outcomes and late effects of treatment in children and adolescents
Classification, cytogenetics, and molecular genetics of acute lymphoblastic leukemia/lymphoma
Clinical use of measurable residual disease detection in acute lymphoblastic leukemia
Detection of measurable residual disease in acute lymphoblastic leukemia/lymphoblastic lymphoma
Hematopoietic cell transplantation (HCT) for acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL) in adults
Induction therapy for Philadelphia chromosome negative acute lymphoblastic leukemia in adults
Induction therapy for Philadelphia chromosome positive acute lymphoblastic leukemia in adults
Mixed phenotype acute leukemia
Overview of the clinical presentation and diagnosis of acute lymphoblastic leukemia/lymphoma in children
Post-remission therapy for Philadelphia chromosome negative acute lymphoblastic leukemia in adults
Post-remission therapy for Philadelphia chromosome positive acute lymphoblastic leukemia in adults
Prognostic factors and risk group stratification for acute lymphoblastic leukemia/lymphoblastic lymphoma in children and adolescents
Relapsed or refractory acute lymphoblastic leukemia/lymphoblastic lymphoma in children and adolescents
Therapeutic use and toxicity of high-dose methotrexate
Treatment of acute lymphoblastic leukemia/lymphoma in children and adolescents
Treatment of relapsed or refractory acute lymphoblastic leukemia in adults
Acute myeloid leukemia in children and adolescents
Acute myeloid leukemia: Induction therapy in medically-fit adults
Acute myeloid leukemia: Management of medically unfit adults
Blastic plasmacytoid dendritic cell neoplasm
Classification of acute myeloid leukemia (AML)
Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia
Cytogenetic abnormalities in acute myeloid leukemia
Familial disorders of acute leukemia and myelodysplastic syndromes
Hyperleukocytosis and leukostasis in hematologic malignancies
Involvement of the central nervous system (CNS) with acute myeloid leukemia (AML)
Mixed phenotype acute leukemia
Molecular genetics of acute myeloid leukemia
Overview of acute myeloid leukemia in adults
Overview of the complications of acute myeloid leukemia
Pathogenesis of acute myeloid leukemia
Post-remission therapy for acute myeloid leukemia in younger adults
Pretreatment evaluation and prognosis of acute myeloid leukemia in older adults
Prognosis of acute myeloid leukemia
Therapy-related myeloid neoplasms: Epidemiology, causes, evaluation, and diagnosis
Therapy-related myeloid neoplasms: Management and prognosis
Treatment of relapsed or refractory acute myeloid leukemia
Clinical manifestations, pathologic features, and diagnosis of acute promyelocytic leukemia in adults
Initial treatment of acute promyelocytic leukemia in adults
Mixed phenotype acute leukemia
Molecular biology of acute promyelocytic leukemia
Treatment of relapsed or refractory acute promyelocytic leukemia in adults
Chronic myelomonocytic leukemia: Clinical features, evaluation, and diagnosis
Chronic myelomonocytic leukemia: Management and prognosis
Clinical features and diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma
Clinical features and diagnosis of hairy cell leukemia
Evaluating response to treatment of chronic lymphocytic leukemia
Hematopoietic cell transplantation in chronic lymphocytic leukemia
Monoclonal B cell lymphocytosis
Natural killer (NK) cell large granular lymphocyte leukemia
Overview of the complications of chronic lymphocytic leukemia
Overview of the treatment of chronic lymphocytic leukemia
Pathobiology of chronic lymphocytic leukemia
Prevention of infections in patients with chronic lymphocytic leukemia
Risk of infections in patients with chronic lymphocytic leukemia
Selection of initial therapy for symptomatic or advanced chronic lymphocytic leukemia/small lymphocytic lymphoma
Staging and prognosis of chronic lymphocytic leukemia
Treatment of T cell prolymphocytic leukemia
Treatment of hairy cell leukemia
Treatment of large granular lymphocyte leukemia
Treatment of relapsed or refractory chronic lymphocytic leukemia
Chromosomal translocations, deletions, and inversions
Cytogenetic abnormalities in acute myeloid leukemia
Cytogenetics, molecular genetics, and pathophysiology of myelodysplastic syndromes/neoplasms (MDS)
General aspects of cytogenetic analysis in hematologic malignancies
Genetic abnormalities in hematologic and lymphoid malignancies
Pathobiology of chronic lymphocytic leukemia
Tools for genetics and genomics: Cytogenetics and molecular genetics
Clinical manifestations, pathogenesis, and diagnosis of essential thrombocythemia
Prognosis and treatment of essential thrombocythemia
Clinical manifestations, diagnosis, and classification of myelodysplastic syndromes (MDS)
Clonal hematopoiesis of indeterminate potential (CHIP) and related disorders of clonal hematopoiesis
Cytogenetics, molecular genetics, and pathophysiology of myelodysplastic syndromes/neoplasms (MDS)
Juvenile myelomonocytic leukemia
Myelodysplastic syndromes/neoplasms (MDS): Management of hematologic complications in lower-risk MDS
Overview of the treatment of myelodysplastic syndromes
Prognosis of myelodysplastic neoplasms/syndromes (MDS) in adults
Treatment of high or very high risk myelodysplastic syndromes
Treatment of lower-risk myelodysplastic syndromes (MDS)
Accelerated phase chronic myeloid leukemia: Diagnosis and treatment
Cellular and molecular biology of chronic myeloid leukemia
Clinical manifestations and diagnosis of chronic myeloid leukemia
Clinical manifestations and diagnosis of polycythemia vera
Clinical manifestations and diagnosis of primary myelofibrosis
Clinical manifestations, pathogenesis, and diagnosis of essential thrombocythemia
Hematopoietic cell transplantation in chronic myeloid leukemia
Initial treatment of chronic myeloid leukemia in chronic phase
Molecular genetics of chronic myeloid leukemia
Molecular pathogenesis of congenital erythrocytoses and polycythemia vera
Myelofibrosis (MF): Management of primary MF and secondary MF
Myeloid leukemia associated with Down syndrome (ML-DS)
Overview of the myeloproliferative neoplasms
Overview of the treatment of chronic myeloid leukemia
Pathogenetic mechanisms in primary myelofibrosis
Prognosis and treatment of polycythemia vera and secondary polycythemia
Prognosis of primary myelofibrosis
Transient abnormal myelopoiesis (TAM) of Down syndrome (DS)
Treatment of chronic myeloid leukemia in blast crisis
Treatment of chronic myeloid leukemia in chronic phase after failure of initial therapy
Clinical manifestations and diagnosis of polycythemia vera
Molecular pathogenesis of congenital erythrocytoses and polycythemia vera
Prognosis and treatment of polycythemia vera and secondary polycythemia
Clinical manifestations and diagnosis of primary myelofibrosis
Myelofibrosis (MF): Management of primary MF and secondary MF
Pathogenetic mechanisms in primary myelofibrosis
Prognosis of primary myelofibrosis

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟